Why Attend
Be part of the movement as CAR-T Therapy shapes the future of oncology.
The promise of the revolutionary oncology treatment, CAR-T therapy, has become a reality this year, with end-stage cancer patients treated on public health services across the world. As CAR-T moves into the public domain, battle has commenced in the race to effectively commercialise this ground-breaking therapy.
The CAR-T Congress is bringing together leading biotechs, late-stage researchers and global pharmaceutical leaders to promote and share research that will break down barriers in R&D through novel data. In our fourth annual congress, we are introducing a new pre-day focused on NK Cell Therapy and the event will run alongside our Vein-to-Vein Congress, so you can tailor your agenda and learn more about cell therapies and their manufacturing.
Having listened to the market demands, this year we will be bringing you even more industry-driven understanding of translational applications of the science that drives R&D in CAR-T. Tackle the next hurdles for allogeneic treatments by limiting graft vs host disease through the use of iPSC, and increase the efficacy of these treatments in solid tumours through combination therapies and solid tumour manipulation.
Talks run by biotechs, pharma and regulatory bodies, will put you in a position to make informed decisions when commercialising your CAR-T therapy.
2019 IMAGE GALLERY
TESTIMONIALS
WHO WILL BE THERE
Network with industry experts from:
- Big pharma and biotech
- Cell Therapy Academics and clinicians
- Process standardisation - technology/services
- Logistics companies - cell storage/transport
- Service providers - CRO’s, Consultants, Government
Past attendees include:
The Agenda
We are excited to bring you the agenda for our fourth annual CAR-T Congress EU. This agenda shows you the new talks and other big changes coming this year. We are looking forward to having you back...
Check out the highlights from the CAR-T Congress USA 2018:
Download agenda
The Speakers
Mark Creighton-Gutteridge
Bob Valamehr, PhD MBA,
Peggy Sotiropoulou
Dr John Maher
Professor Hinrich Abken
Fiona Thistlethwaite
Dr. Stefanos Theoharis
Karl-Johan Malmberg
Professor Ann Ager
Jo Tomlins
Dr Sophie Papa
Sophie Papa is a Senior Lecturer and Consultant Medical Oncologist at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust. Sophie undertook her medical training at the University of Oxford and Imperial College London. She completed a PhD in cancer immunotherapy from King’s College London in 2011. She is a clinical academic with research interests in the field of immune-oncology. Her research interests include developing approaches to optimise personalised cell based immune therapies for solid tumour oncology and understanding adverse immune reactions triggered by checkpoint inhibitor therapy. She is also interested in the delivery of complex cell therapy trials for solid tumour indications. Sophie is a medical oncologist with a practice in malignant melanoma and is the lead for skin cancer research at Guy’s and St Thomas’ NHS Foundation Trust.
Roberto Spada
Jacqueline Barry
Matthew Cobb
Professor Graham Pockley
David Finlay
Salim Khakoo
Prof. Torsten Tonn
Adrian Bot
Deepak Raj
Duncan McKay
Stefan Wildt
Pierre Heimendinger
Emanuele Ostuni
Louise Bisset
Qasim Rafiq
Ali Mohamed
Dr Detlev Parow
Poster Session: CAR-T Congress EU 2020
Our dedicated poster session is the perfect way to get your research noticed. In order to present a poster at the forum, you need to be registered as a delegate. Please note that there are 15 assigned spaces for the CAR-T Congress and 10 for the NK Summit Day. Poster space is assigned on a first come, first served basis (subject to checks and successful registration).
At the Congress, your presentation will be displayed in a dedicated poster area. The poster presentation session will take place at the afternoon networking break on day one.
Poster abstract submission deadline is on 6th December 2019. Abstracts received after this time may not be accepted so please submit your abstract as soon as possible!
Posters should be sized A0 (841mm x 1189mm) in portrait orientation.
Expertise Partner
Miltenyi Biotec
Website: http://www.miltenyibiotec.com
At Miltenyi Biotec, we are committed to enabling the delivery of new cell and gene therapy (CGT) treatment options to patients with unmet medical needs. We develop tailored cell processing protocols for our GMP-compliant cell processing platform, the CliniMACS Prodigy®, to enable fully closed and automated manufacturing of complex CGT products. In addition, we offer contract development and GMP manufacturing of CGT products as well as design, development, and production of tailored GMP lentiviral vectors
Innovation Partner
Fluidigm
Website: http://www.fluidigm.com
Fluidigm is committed to empowering the cancer immunotherapy community
with research tools to interrogate immune cell function and the tumor
microenvironment with unprecedented resolution.
Using proven mass cytometry and microfluidic technologies, we provide
workflows to identify and characterize changes in cellular phenotypes at
single-cell resolution. Whether you seek to target new biomarkers and
pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells
or cancer vaccines,
Fluidigm can help you identify new insights to reach your next research
breakthrough. Together we will transform the future of cancer care.
nanoString
Website: https://www.nanostring.com/
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System, which has been employed in basic and translational research and cited in 1,000+ peer review publications, has also now been applied to diagnostic use with the nCounter Dx Analysis System. The company is committed to offering tools that enable scientists and clinicians to translate today’s leading genomic research into clinically actionable tests that improve patient care. Gene expression panels for immune- oncology, autoimmunity, CAR-T and other applications are ready off the shelf tools offered to the Nanostring customers.
Event Partner
CellGenix
Website: http://www.cellgenix.com
CellGenix is a leading global supplier of high quality reagents and tools in the expanding market of cell and gene therapy and regenerative medicine.
As the first company to obtain a GMP manufacturing authorization for cell processing in Europe, CellGenix has more than 20 years of expertise in the development and GMP manufacturing of cell therapy products. Our products are used worldwide in clinical trials by academia and industry partners.
To ensure a seamless transition from research to commercialization we offer our customers a comprehensive product portfolio together with expert regulatory and technical support. Included in our product portfolio are cytokines, serum-free media and closed cell culture systems. Our products combine a maximum of quality and safety with excellent performance due to the state-of-the-art production, stringent in-house quality control and comprehensive documentation. All these factors help to simplify qualification and validation for your market authorization.
CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA.
Bio- Techne
Website: https://www.bio-techne.com/
The Bio-Techne family of brands offer a unique portfolio of high-quality reagents, instruments and services for life science researchers. To enable scientists working in the rapidly growing field of Targeted Protein Degradation, Bio-Techne provides a bespoke range of tools and reagents for the discovery, development and application of Degraders as well as custom services.
- Active Degraders and Degrader Building Blocks: The Tocris brand has pioneered commercialization of tool Degraders to make them available to the research community for investigating the phenotypic consequences of targeted protein knockdown. Tocris also supplies chemical building blocks (functionalized E3 ligase ligands plus linkers) to enable researchers to generate their own Degraders and offers custom synthesis of bespoke panels of Degrader Building Blocks.
- Ubiquitin Proteasome System (UPS) Proteins and Assays: Boston Biochem is the leading global provider of UPS related research products, with a catalog that includes UPS proteins, related antibodies and assay kits, as well as custom expertise in protein purification, characterization, modification, and assay development.
- Assays for Protein Degradation: Simple WesternTM systems from ProteinSimple, such as Wes™ and Jess, simplify and accelerate the detection of Degrader-mediated protein knockdown by automating the entire protein separation and detection process.
Cell & Gene Therapy Catapult
Website: https://ct.catapult.org.uk/
Please visit our website for more information.IsoPlexis
Website: http://www.isoplexis.com
IsoPlexis is dedicated to accelerating the fight against cancer and a range of the world’s toughest diseases with our uniquely correlative, award-winning single-cell detection systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise & personalized stage. Our integrated systems, named #1 innovation by the Scientist Magazine & Fierce, are used globally to advance the field of single-cell biology and biomarkers as we generate solutions to overcome the challenges of complex diseases.
Learn more at: www.isoplexis.com
Become a Partner
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920, email Duncan Henderson at [email protected] or downloading our agenda and clicking the "Interested in Sponsorship" box below.
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Book a Team to Save More!
PLEASE NOTE: Team Discounts are only available for Industry Pricing
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
Payment Terms for Combined CAR-T Congress Europe:
- Please note that a £49 processing fee will apply to any invoices requested.
- All Prices are in GBP and are exclusive of VAT @ 20%
- All Early Bird discount prices, including Group Discounts, must be paid in full by deadlines provided above.
- No discounts or offers can be combined with any other offer.
- Please view our Cancellation Policy.
- QUESTIONS? Please email [email protected].
Pass Features:
- 2 Day conference pass
- Networking Sessions
- Lunch and Refreshments
Complimentary Articles and Content
Venue
Leonardo Royal Hotel London City, 8-14 Cooper’s Row, London, EC3N 2BQ
We are delighted to be returning to London for the 4th Annual CAR-T Congress EU. The Leonardo Royal Hotel London is very close to Tower Hill station, located in Zone 1.
We have a number of discounted rooms available for the event at the hotel itself:
27 Jan - £159.00 incl VAT & breakfast, single occupancy
28 Jan - £179.00 incl VAT & breakfast, single occupancy
To book call: +44 (0) 161 774 1742
or email: [email protected]
Quote the Block Code: LHKISA270120.
Card details required when making a booking. Rooms are available until 27 December 2019 on the above rate. After this date rates will be subject to availability.
+44 (0) 161 774 1742
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
